Suerie Moon’s Synthesis and Conclusions of Geneva Graduate Institute’s Global Health Centre workshop on technology transfer in January 2025. Published in Medicines Law and Policy 12 Feb 2025.
Technology transfer has been one of the more politically and technically difficult issues on which to forge consensus in the Pandemic Agreement negotiations. In the wake of the Covid-19 pandemic—which was characterized by shortages of health products, widespread trade barriers and highly-unequal and inequitable access to pandemic products—there is widespread agreement on the importance of diversifying production capacity by strengthening it in low and middle-income countries (LMICs). All countries stand to benefit if the world can produce sufficient volumes of products to get a pandemic emergency under control as quickly as possible, by reducing the risk of ongoing spread and ending the emergency faster.
Read more here
Leave a Reply